Vital Signs - The Analysts Perspective - November Issue

Regular Price: USD 500

Special Price USD 450

10% OFF

* Required Fields

Regular Price: USD 500

Special Price USD 450

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on December 5, 2014, discusses LabCorp's acquisition of Covance, MedImmune's acquisition of Definiens, the Google X cancer and heart attack detector, and VWR's acquisition of two fluid handling components companies.

Table of Contents

Vital Signs - The Analyst's Perspective - November IssueVital Signs - November 2014This week's issue




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.